A recent study (Feng, Yang & Yan, 2020) compared serum MEG3 expression level in 119 asthma patients and 125 healthy controls and found significantly lower serum MEG3 level in asthma patients than in controls and the expression level was the lowest in mixed granulocytic asthma (the subtype with the most severe symptoms). This evidence concerns the gene MEG3 and asthma.